The performance of companies tied to the drug's legacy presents a complex investment scenario . While the initial surge generated substantial returns , generic alternatives have significantly eroded sales . https://allkindsofsocial.com/story7023229/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-opportunity